GlobeNewswire
Protara Therapeutics Receives Both FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in Pediatric Patients with Lymphatic Malformations
📈
AI Sentiment
Highly Positive
9/10
Protara Therapeutics Inc. News
Latest updates and market news for TARA
1 news
Dec 31 - Jan 6, 2026
Page 1
Share this news page